Reported Friday, ImmunoPrecise Antibodies Receives Nasdaq Deficiency Notification For Falling Below $1.00 Bid Price Threshold
Portfolio Pulse from Benzinga Newsdesk
ImmunoPrecise Antibodies received a Nasdaq deficiency notification for its stock falling below the $1.00 bid price threshold. This notification does not imply imminent delisting and has no immediate effect on the trading of the company's shares.
August 26, 2024 | 6:26 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ImmunoPrecise Antibodies received a Nasdaq deficiency notification for its stock falling below the $1.00 bid price threshold. This notification does not imply imminent delisting and has no immediate effect on the trading of the company's shares.
The notification indicates that IPA's stock is under the $1.00 bid price threshold, which is a concern for investors as it could lead to delisting if not corrected. However, there is no immediate effect on trading, and the company has time to address the issue.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100